Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Nicol Keith

Showing results (1-10 of 61) with videos related to

Pageof 7
Sort By:
Oncogene|April 27, 2004
From stem cells to cancer: balancing immortality and neoplasiaW Nicol Keith
European Journal of Cancer (Oxford, England : 1990)|May 9, 2006
Therapeutic potential of adult stem cellsNedime Serakinci, W Nicol Keith
Expert Reviews in Molecular Medicine|November 21, 2007
Stem cell ageing: does it happen and can we intervene?Ilaria Bellantuono, W Nicol Keith
Expert Reviews in Molecular Medicine|March 14, 2007
Epigenetic control of cellular senescence in disease: opportunities for therapeutic interventionStuart P Atkinson, W Nicol Keith
Journal of Cellular and Molecular Medicine|January 5, 2011
Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectivesAlan E Bilsland, Claire J Cairney, W Nicol Keith
BMC Cancer|January 20, 2005
MDM2 negatively regulates the human telomerase RNA gene promoterJiangqin Zhao, Alan Bilsland, Katrina Jackson, et al.
Neoplasia (New York, N.Y.)|December 8, 2005
Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapyAlan E Bilsland, Aileen Fletcher-Monaghan, W Nicol Keith
FEBS Letters|February 15, 2003
Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA geneJiangqin Zhao, Alan Bilsland, Stacey F Hoare, et al.
Cancer Research|February 7, 2007
Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenovirusesAlan E Bilsland, Andrew Merron, Georges Vassaux, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 4, 2010
Modulation of gene expression using zinc finger-based artificial transcription factorsSabine Stolzenburg, Alan Bilsland, W Nicol Keith, et al.
Pageof 7

Showing results (1-10 of 61) with videos related to

Sort By:
Pageof 7
Oncogene|April 27, 2004
From stem cells to cancer: balancing immortality and neoplasiaW Nicol Keith
European Journal of Cancer (Oxford, England : 1990)|May 9, 2006
Therapeutic potential of adult stem cellsNedime Serakinci, W Nicol Keith
Expert Reviews in Molecular Medicine|November 21, 2007
Stem cell ageing: does it happen and can we intervene?Ilaria Bellantuono, W Nicol Keith
Expert Reviews in Molecular Medicine|March 14, 2007
Epigenetic control of cellular senescence in disease: opportunities for therapeutic interventionStuart P Atkinson, W Nicol Keith
Journal of Cellular and Molecular Medicine|January 5, 2011
Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectivesAlan E Bilsland, Claire J Cairney, W Nicol Keith
BMC Cancer|January 20, 2005
MDM2 negatively regulates the human telomerase RNA gene promoterJiangqin Zhao, Alan Bilsland, Katrina Jackson, et al.
Neoplasia (New York, N.Y.)|December 8, 2005
Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapyAlan E Bilsland, Aileen Fletcher-Monaghan, W Nicol Keith
FEBS Letters|February 15, 2003
Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA geneJiangqin Zhao, Alan Bilsland, Stacey F Hoare, et al.
Cancer Research|February 7, 2007
Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenovirusesAlan E Bilsland, Andrew Merron, Georges Vassaux, et al.
Methods in Molecular Biology (Clifton, N.J.)|August 4, 2010
Modulation of gene expression using zinc finger-based artificial transcription factorsSabine Stolzenburg, Alan Bilsland, W Nicol Keith, et al.
Pageof 7